津巴布韦农村婴儿口服轮状病毒疫苗免疫原性的预测因素
本研究基于津巴布韦农村SHINE试验的子队列,分析219名婴儿的轮状病毒疫苗血清转化数据,发现20%成功血清转化,较高年龄别身长Z评分与血清转化正相关,同时接种口服脊髓灰质炎疫苗与血清转化负相关。在472名婴儿中,较高年龄别身长Z评分与血清阳性率正相关,较高出生体重与IgA滴度正相关。
要点
- 婴儿线性生长(年龄别身长Z评分)与轮状病毒疫苗免疫原性正相关。
- 同时接种口服脊髓灰质炎疫苗与轮状病毒疫苗血清转化负相关。
- 较高出生体重与接种后轮状病毒IgA滴度升高相关。
核心结论
- 婴儿体重和线性生长与轮状病毒疫苗免疫原性正相关,而同时接种口服脊髓灰质炎疫苗与免疫原性负相关;改善胎儿生长和分开接种轮状病毒疫苗与口服脊髓灰质炎疫苗可能是提高免疫原性的可行方法。
研究设计与样本
- 基于津巴布韦农村SHINE整群随机试验的子队列研究,纳入219名有血清转化数据的婴儿和472名有接种后滴度数据的婴儿,分析危险因素与轮状病毒疫苗免疫原性的关联。
主要发现
- 在219名婴儿中,43名(20%)成功血清转化,176名(80%)未血清转化。
- 较高年龄别身长Z评分与血清转化正相关(调整RR 1.27,95%CI 1.04-1.55,P=0.021)。
- 同时接种口服脊髓灰质炎疫苗与轮状病毒疫苗与血清转化负相关(调整RR 0.36,95%CI 0.19-0.71,P=0.003)。
- 在472名婴儿中,较高年龄别身长Z评分与血清阳性率升高相关(调整RR 1.21,95%CI 1.06-1.38,P=0.004)。
- 出生体重每增加100克,接种后IgA滴度增加0.45 U/mL(95%CI 0.18-1.09,P=0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Oral rotavirus vaccines (RVV) have poor immunogenicity in low-income countries, for reasons that remain unclear. This study identified the determinants of RVV immunogenicity among infants in rural Zimbabwe. METHODS: Anti-rotavirus IgA titres were measured among a sub-group of infants enrolled in the Sanitation Hygiene Infant Nutrition Efficacy (SHINE) trial (NCT01824940). SHINE was a cluster-randomized trial of improved infant and young child feeding, and improved water, sanitation and hygiene (WASH) in two rural Zimbabwean districts. Infants received RVV as part of the national immunisation programme. Among HIV-unexposed infants in the non-WASH trial arms, we evaluated associations between potential risk factors (vaccine schedule and dose, maternal and infant nutritional status, infant diarrhoea, and household environment) and RVV immunogenicity (seroconversion, seropositivity and geometric mean titres) using multivariable regression. RESULTS: Among 219 infants with seroconversion data, 43 (20%) successfully seroconverted and 176 (80%) failed to seroconvert to RVV. Seroconversion was positively associated with a higher length-for-age Z-score (LAZ) around the time of vaccination (adjusted RR 1.27 (95% CI 1.04, 1.55), P = 0.021), and negatively associated with concurrent OPV and RVV administration (adjusted RR 0.36 (0.19, 0.71), P = 0.003). Among 472 infants with post-vaccination titres, a higher LAZ score was associated with increased seropositivity (aRR 1.21 (95% CI 1.06, 1.38), P = 0.004), and higher birthweight was associated with increased IgA titres (0.45 (95%CI 0.18, 1.09) U/mL greater per 100 g gain in birthweight; P = 0.001). CONCLUSIONS: Infant ponderal and linear growth were positively associated with RVV immunogenicity, while concurrent administration of OPV was negatively associated with RVV immunogenicity. Together, these findings suggest that improving foetal growth and separating RVV and OPV administration are plausible approaches to increasing RVV immunogenicity.
引用
- Church JA, Chasekwa B, Rukobo S, et al. Predictors of oral rotavirus vaccine immunogenicity in rural Zimbabwean infants. Vaccine. 2020. PMID: 32088018. doi:10.1016/j.vaccine.2020.01.097
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。